Pfizer’s Lipitor Faces Colluding Charges in Australia

Amid the growing lawsuits and controversy that Pfizer’s Lipitor causes type-2 diabetes in female patients between the ages of 50 and 79 with BMI (Body Mass Index) below 30, (See California coordinated Lipitor cases in Los Angeles Superior Court JCCP no. 4761; In re Lipitor (Atorvastatin) Litigation, MDL No. 2502 (JPML)), Pfizer faces more legal [...]

February 24th, 2014|Drug and Medical Device Litigation, Lipitor|Comments Off on Pfizer’s Lipitor Faces Colluding Charges in Australia

In 2013, Lipitor, Diabetes, and Post Menopausal Women Controversy Finally Gets Attention

Thanks to all of our regular readers of The Brandi Law Firm Blog.  We try to write about matters that we are involved in representing consumers in the area of defective drugs and devices, consumer issues, and auto safety.  We have seen our readership grow by fivefold this year and we thank you for your interest. [...]

December 27th, 2013|Drug and Medical Device Litigation, Lipitor|Comments Off on In 2013, Lipitor, Diabetes, and Post Menopausal Women Controversy Finally Gets Attention